{"entity":{"id":"kunle-odunsi","kind":"person","name":"Kunle Odunsi","aka":[],"tldr":"Gynaecologic oncologist and immunotherapy researcher who directs the University of Chicago Medicine Comprehensive Cancer Center.","summary":"Kunle Odunsi, MD, PhD, is Director of the University of Chicago Medicine Comprehensive Cancer Center, an NCI-designated comprehensive cancer centre. A gynaecologic oncologist, his research focuses on immunotherapy and vaccine therapy for cancer, particularly ovarian cancer, including NY-ESO-1 targeted vaccines and adoptive T-cell approaches. His role is listed on the centre's leadership page.","asOf":"2026-09-10","wikipedia":"https://en.wikipedia.org/wiki/Kunle_Odunsi","links":[{"label":"Institution profile","url":"https://www.uchicagomedicine.org/cancer/about-us/leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Odunsi+K%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","immunotherapy","ovarian cancer"],"related":[],"cancers":["ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["uchicago-cancer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director","institutionId":"uchicago-cancer","specialisms":["Gynaecologic oncology","Cancer immunotherapy","Cancer vaccines","Ovarian cancer"],"profiles":[{"label":"Institution profile","url":"https://www.uchicagomedicine.org/cancer/about-us/leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Odunsi+K%5BAuthor%5D"}],"papers":[{"title":"CXCR6 by increasing retention of memory CD8 + T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer","journal":"Journal for ImmunoTherapy of Cancer","year":2021,"doi":"10.1136/jitc-2021-003329"},{"title":"Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses","journal":"Science Translational Medicine","year":2022,"doi":"10.1126/scitranslmed.abg8402"},{"title":"IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation","journal":"Frontiers in Immunology","year":2021,"doi":"10.3389/fimmu.2021.678999"}],"orcid":"0000-0002-4444-7651"},"route":"/people/kunle-odunsi/","neighbours":{"cancer":[{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"institution":[{"id":"uchicago-cancer","kind":"institution","name":"University of Chicago Medicine Comprehensive Cancer Center","route":"/institutions/uchicago-cancer/"}]}}